Global Healthcare-associated infection (HAI) Market By Product (Consumables, Analyzers/Instruments), By Pathogen (Viral, Bacterial and Fungal), By Treatment (Sterilization, Chemical, Radiation), By Infections (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, BloodStream Infections, Gastrointestinal Infections, Respiratory infections. Other Healthcare-associated Infections), By Diagnostic Tests (Traditional Diagnostics, and Molecular Diagnostics) By End Use (Hospitals, Clinics, ASCs, and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027
Market Analysis and Insights of Global Healthcare-Associated Infection (HAI) Market
Healthcare-associated infection (HAI) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 54.57 billion by 2027 growing at the annual growth rate of (CAGR) 8.0% in the above-mentioned forecast period. The spreading knowledge amongst the physicians and patients about the advantages blended with the usage of healthcare-associated infection (HAI) has been instantly reshaping the growth of healthcare-associated infection (HAI) market.
Healthcare-associated infection (HAI) depicts its meaning from the name, they are commonly acquired infections induced in the patients from external sources in the hospitals or healthcare centers. Owing to this factor all the type of healthcare centers such are hospitals, clinics, pathologies are adopting measures to reduce the possibilities of infections and contamination by sterlizing the services offered in these point of care institutes. Market growth of HAI is directly proportional to the contagious ratio which is critically required to control, can be achieved through certain standard adoption while examination of patients. Namely molecular diagnostic testing and accelerating improvements in the diagnostic testing sector will propel the market growth and success factor of healthcare-associated infection (HAI) solely.
In November 2019, the visual input to drive the market can be observed in the recent acquisition established between Beijing Hanmi Pharmaceutical Co., Ltd. and Innovent Biologics, Inc. The prominent healthcare enterprises joined together for the business venture in developing and commercializing better quality medicines for treating metabolic, oncology and, autoimmune and other major contagious diseases and asserts to continue the collaboration with the focus of catering high-level clinical and market advancements.
This healthcare-associated infection (HAI) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research healthcare-associated infection (HAI) market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Market Scope and Market Size of Healthcare-associated infection (HAI)
Healthcare-associated infection (HAI) market is segmented of the basis of product, pathogens, method of treatment, infections, diagnostic tests, and end use. The growth amongst these sections will help you interpret lean growth segments in the enterprises, and will provide the users a relevant market overview and market penetrations to help them in making strategic decision for the identification of core market demands.
- Based on product, the healthcare-associated infection (HAI) market is segmented into consumables, and analyzers/instruments.
- Based on pathogens, the healthcare-associated infection (HAI) market is segmented into viral, bacterial, and fungal. Bifurcations on the basis of treatment are sterilization, chemical, and radiation.
- Based on the type of infections, healthcare-associated infection (HAI) market is segmented into urinary tract infections, surgical site infections, hospital-acquired pneumonia, bloodstream infections, gastrointestinal infections, respiratory infections and other healthcare-associated infections.
- Segmentation on the basis of diagnostics test in the healthcare-associated infection (HAI) market is traditional diagnostics, molecular diagnostics.
- Healthcare-associated infection (HAI) market has also been segmented based on the end use into hospitals, clinics, ASCs, others.
Healthcare-associated infection (HAI) Market Country Level Analysis
Healthcare-associated infection (HAI) market is analysed and market size insights and trends are provided by country, product pathogens, and method of treatment, infections, diagnostic tests, and end use as referenced above.
The countries covered in the healthcare-associated infection (HAI) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America anticipated beholding skyward germination in denominations of revenue, with prime players concentrating on flourishing innovations and developed contagious infection diagnostics goods adding to the yield of the market in the outlook period of 2020 to 2027 due to the focus of various established market players to expand their presence in this particular region.
Following the same trails of exceptional increment European regions such as Italy, Spain, and Portugal are inducing healthcare-associated infection (HAI) modules to gain high stakes in market.
The country section of the healthcare-associated infection (HAI) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Data bridge market research firm also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for healthcare-associated infection (HAI) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the healthcare-associated infection (HAI) market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Healthcare-associated infection (HAI) Market Share Analysis
Healthcare-associated infection (HAI) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to healthcare-associated infection (HAI) market.
The major business players and prime market dominators covered in the healthcare-associated infection (HAI) market report are HORIBA, Ltd., BD., bioMérieux, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience, QIAGEN, ASP, Fortive, Johnson & Johnson Services, 3M, STERIS plc., Getinge AB., Cantel Medical., Belimed, Trinity Biotech, DiaSorin, OpGen, Accelerate Diagnostics, Thermo Fisher Scientific, Bio-Rad, Luminex Corporation., Quidel Corporation. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Healthcare-Associated Infection (HAI) Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.